Abstract:Lipid droplets (LD) have long been considered as mere fat drops; however, LD have lately been revealed to be ubiquitous, dynamic and to be present in diverse organelles in which they have a wide range of key functions. Although incompletely understood, the biogenesis of eukaryotic LD initiates with the synthesis of neutral lipids (NL) by enzymes located in the endoplasmic reticulum (ER). The accumulation of NL leads to their segregation into nanometric nuclei which then grow into lenses between the ER leaflets as they are further filled with NL. The lipid composition and interfacial tensions of both ER and the lenses modulate their shape which, together with specific ER proteins, determine the proneness of LD to bud from the ER toward the cytoplasm. The most important function of LD is the buffering of energy. But far beyond this, LD are actively integrated into physiological processes, such as lipid metabolism, control of protein homeostasis, sequestration of toxic lipid metabolic intermediates, protection from stress, and proliferation of tumours. Besides, LD may serve as platforms for pathogen replication and defense. To accomplish these functions, from biogenesis to breakdown, eukaryotic LD have developed mechanisms to travel within the cytoplasm and to establish contact with other organelles. When nutrient deprivation occurs, LD undergo breakdown (lipolysis), which begins with the LD-associated members of the perilipins family PLIN2 and PLIN3 chaperone-mediated autophagy degradation (CMA), a specific type of autophagy that selectively degrades a subset of cytosolic proteins in lysosomes. Indeed, PLINs CMA degradation is a prerequisite for further true lipolysis, which occurs via cytosolic lipases or by lysosome luminal lipases when autophagosomes engulf portions of LD and target them to lysosomes. LD play a crucial role in several pathophysiological processes. Increased accumulation of LD in non-adipose cells is commonly observed in numerous infectious diseases caused by intracellular pathogens including viral, bacterial, and parasite infections, and is gradually recognized as a prominent characteristic in a variety of cancers. This review discusses current evidence related to the modulation of LD biogenesis and breakdown caused by intracellular pathogens and cancer.

Lipid droplets: a cellular organelle vital in cancer cells

Lipid Droplet and Its Implication in Cancer Progression.

Adding fuel to the fire: The lipid droplet and its associated proteins in cancer progression

Lipid droplets provide metabolic flexibility for cancer progression

The lipid droplet in cancer: From being a tumor‐supporting hallmark to clinical therapy

Emergence of Lipid Droplets in the Mechanisms of Carcinogenesis and Therapeutic Responses

Biogenesis and Breakdown of Lipid Droplets in Pathological Conditions

Cancer cells employ lipid droplets to survive toxic stress

Lipid droplets: platforms with multiple functions in cancer hallmarks

Lipid Droplets, the Central Hub Integrating Cell Metabolism and the Immune System

Are lipid droplets the picnic basket of brain tumours?

Adipocyte‐Derived Anticancer Lipid Droplets

Lipid Droplets in Lung Cancers Are Crucial for the Cell Growth and Starvation Survival

The dynamic behavior of lipid droplets in the pre-metastatic niche

Imaging lipid droplet fusion and growth.

Roles of lipid droplets and related proteins in metabolic diseases

The biogenesis of lipid droplets: Lipids take center stage

Lipid Droplet Contact Sites in Health and Disease

Lipid droplets and fatty acid‐induced lipotoxicity: in a nutshell

Lipid Droplets: Formation, Degradation, and Their Role in Cellular Responses to Flavivirus Infections

Application of Synthetic Lipid Droplets in Metabolic Diseases.